Differential optical densities of intraretinal spaces

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 8, 2008, Pages 3529-3534

  Barthelmes, Daniel ^a   Sutter, Florian K P ^b   Gillies, Mark C ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CENTRAL SEROUS RETINOPATHY; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; EXUDATIVE RETINITIS; FEMALE; HUMAN; IMAGE ANALYSIS; INTRARETINA SPACE; LIGHT REFRACTION; MALE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL DENSITY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA; RETINA DEGENERATION; RETINA DYSTROPHY; RETINA MACULA LUTEA; RETINITIS PIGMENTOSA; RETROSPECTIVE STUDY; TELANGIECTASIA; VITREOUS BODY; CYST; ELECTRORETINOGRAPHY; EXUDATE; FLUORESCENCE ANGIOGRAPHY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETINA DISEASE; VISUAL SYSTEM EXAMINATION;

ADULT; CYSTS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; ELECTRORETINOGRAPHY; EXUDATES AND TRANSUDATES; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MIDDLE AGED; RETINA; RETINAL DISEASES; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 49049099240     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1320     Document Type: Article

References (24)

1. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007;143(4):566-583.
2. Massin P, Duguid G, Erginay A, Haouchine B, Gaudric A. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol. 2003;135(2):169-177.
3. Melo GB, Farah ME, Aggio FB. Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa. Acta Ophthalmol Scand. 2007;85(4):461-463.
4. Gaudric A, Ducos de Lahitte G, Cohen SY, Massin P, Haouchine B. Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol. 2006;124(10):1410-1419.
5. Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology. 1993;100(10):1536-1546.
6. Gass JD, Oyakawa RT. Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol. 1982;100(5):769-780.
7. Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch Ophthalmol. 2006;124(4):450-460.
8. Michaelides M, Hunt DM, Moore AT. The cone dysfunction syndromes. Br J Ophthalmol. 2004;88(2):291-297.
9. Simunovic MP, Moore AT. The cone dystrophies. Eye. 1998;12:553-565.
10. Paunescu LA, Ko TH, Duker JS, et al. Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006;113(1):48-57.
11. Barthelmes D, Gillies MC, Fleischhauer JC, Sutter FK. A case of idiopathic perifoveal telangiectasia preceded by features of cone dystrophy. Eye. 2007;21(12):1534-1535.
12. Barthelmes D, Sutter FK, Kurz-Levin MM, et al. Quantitative analysis of OCT characteristics in patients with achromatopsia and blue-cone monochromatism. Invest Ophthalmol Vis Sci. 2006;47(3):1161-1166.
13. Gerber DM, Munier FL, Niemeyer G. Cross-sectional study of visual acuity and electroretinogram in two types of dominant drusen. Invest Ophthalmol Vis Sci. 2003;44(2):493-496.
14. Marmor MF, Zrenner E. Standard for clinical electroretinography (1999 update). International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol. 1998;97(2):143-156.
15. Surguch V, Gamulescu MA, Gabel VP. Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol. 2007;245(6):783-788.
16. Charbel Issa P, Holz FG, Scholl HP. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology. 2007;114(9):1736-1742.
17. Schulze S, Mennel S. Treatment of idiopathic juxtafoveolar retinal telangiectasis with bevacizumab (avastin) (in German). Klin Monatsbl Augenheilkd. 2007;224(10):787-790.
18. Cohen SM, Cohen ML, El-Jabali F, Pautler SE. Optical coherence tomography findings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis. Retina. 2007;27(1):59-66.
19. Koizumi H, Iida T, Maruko I. Morphologic features of group 2A idiopathic juxtafoveolar retinal telangiectasis in three-dimensional optical coherence tomography. Am J Ophthalmol. 2006;142(2):340-343.
20. Gass JD. Müller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacular retinoschisis. Arch Ophthalmol. 1999;117(6):821-823.
21. Vinores SA, Kuchle M, Derevjanik NL, et al. Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization. Histol Histopathol. 1995;10(4):913-923.
22. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol. 1996;121(1):26-34.
23. Prunte C, Flammer J. Circulatory disorders of the choroid in patients with central serious chorioretinopathy (in German). Klin Monatsbl Augenheilkd. 1996;208(5):337-339.
24. Qaum T, Xu Q, Joussen AM, et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci. 2001;42(10):2408-2413.